More doctors are using a drug cost tool created by SureScripts than ever before underscoring that price transparency tools that…More
Venclose has received $27 million in Series C funding to expand market share for it venous reflux therapy. This RF…More
Early bird pricing for MedCity INVEST 2020 ends today so register now for this national investing conference for a chance…More
Shares of the biotech company were up following the presentation on the drug, aducanumab, but investment bank analysts continued to…More
ArQule’s lead product candidate is a BTK inhibitor, ARQ-531, designed for heavily pretreated patients with leukemias and lymphomas, particularly those…More
A new eBook explores the different ways public and private insurers are moving the needle forward to integrate and cover…More
Magic Leap aims to apply spatial computing in healthcare to improve surgical planning, medical education and patient consultation but ultimately…More
Read the latest news for Rx.Health, a Mount Sinai spinout that will be featured at the NODE Health conference in…More
The San Diego-based biotech is developing IL-2 therapeutics for cancers as well as autoimmune disorders. Its lead candidate, THOR-707, is…More
EtectRx is one of a few companies helping track medication adherence. But some patients find the tech hard to swallow.More
